{
     "PMID": "21730160",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20111003",
     "LR": "20150204",
     "IS": "1091-6490 (Electronic) 0027-8424 (Linking)",
     "VI": "108",
     "IP": "29",
     "DP": "2011 Jul 19",
     "TI": "CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy.",
     "PG": "12101-6",
     "LID": "10.1073/pnas.1108197108 [doi]",
     "AB": "Emerging genetic and clinical evidence suggests a link between Gaucher disease and the synucleinopathies Parkinson disease and dementia with Lewy bodies. Here, we provide evidence that a mouse model of Gaucher disease (Gba1(D409V/D409V)) exhibits characteristics of synucleinopathies, including progressive accumulation of proteinase K-resistant alpha-synuclein/ubiquitin aggregates in hippocampal neurons and a coincident memory deficit. Analysis of homozygous (Gba1(D409V/D409V)) and heterozygous (Gba1(D409V/+) and Gba1(+/-)) Gaucher mice indicated that these pathologies are a result of the combination of a loss of glucocerebrosidase activity and a toxic gain-of-function resulting from expression of the mutant enzyme. Importantly, adeno-associated virus-mediated expression of exogenous glucocerebrosidase injected into the hippocampus of Gba1(D409V/D409V) mice ameliorated both the histopathological and memory aberrations. The data support the contention that mutations in GBA1 can cause Parkinson disease-like alpha-synuclein pathology, and that rescuing brain glucocerebrosidase activity might represent a therapeutic strategy for GBA1-associated synucleinopathies.",
     "FAU": [
          "Sardi, S Pablo",
          "Clarke, Jennifer",
          "Kinnecom, Cathrine",
          "Tamsett, Thomas J",
          "Li, Lingyun",
          "Stanek, Lisa M",
          "Passini, Marco A",
          "Grabowski, Gregory A",
          "Schlossmacher, Michael G",
          "Sidman, Richard L",
          "Cheng, Seng H",
          "Shihabuddin, Lamya S"
     ],
     "AU": [
          "Sardi SP",
          "Clarke J",
          "Kinnecom C",
          "Tamsett TJ",
          "Li L",
          "Stanek LM",
          "Passini MA",
          "Grabowski GA",
          "Schlossmacher MG",
          "Sidman RL",
          "Cheng SH",
          "Shihabuddin LS"
     ],
     "AD": "Genzyme Corporation, Framingham, MA 01701, USA. pablo.sardi@genzyme.com",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20110705",
     "PL": "United States",
     "TA": "Proc Natl Acad Sci U S A",
     "JT": "Proceedings of the National Academy of Sciences of the United States of America",
     "JID": "7505876",
     "RN": [
          "0 (alpha-Synuclein)",
          "EC 3.2.1.45 (Glucosylceramidase)",
          "EC 3.4.21.64 (Endopeptidase K)"
     ],
     "SB": "IM",
     "MH": [
          "Analysis of Variance",
          "Animals",
          "Blotting, Western",
          "Dependovirus",
          "Endopeptidase K/metabolism",
          "Gaucher Disease/metabolism/*pathology",
          "Gene Transfer Techniques",
          "Genetic Vectors/genetics",
          "Glucosylceramidase/genetics/*metabolism",
          "Hippocampus/cytology/*enzymology",
          "Immunohistochemistry",
          "Mice",
          "alpha-Synuclein/*metabolism"
     ],
     "PMC": "PMC3141921",
     "EDAT": "2011/07/07 06:00",
     "MHDA": "2011/10/04 06:00",
     "CRDT": [
          "2011/07/07 06:00"
     ],
     "PHST": [
          "2011/07/07 06:00 [entrez]",
          "2011/07/07 06:00 [pubmed]",
          "2011/10/04 06:00 [medline]"
     ],
     "AID": [
          "1108197108 [pii]",
          "10.1073/pnas.1108197108 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):12101-6. doi: 10.1073/pnas.1108197108. Epub 2011 Jul 5.",
     "term": "hippocampus"
}